Verici DX (VRCI) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Dec 2023 07:00 AM
RNS
Tutivia™ validation study published in Journal
29 Nov 2023 07:00 AM
RNS
ISO 27001 Information Security Certification
20 Nov 2023 07:00 AM
RNS
Investor Presentation
15 Nov 2023 07:00 AM
RNS
Commercialisation agreement with Thermo Fisher
02 Nov 2023 07:00 AM
RNS
Clarava™ poster to be presented at ASN Kidney Week
29 Sep 2023 07:00 AM
RNS
Half-year Report
20 Jul 2023 07:00 AM
RNS
CLIA Certificate of Compliance update
06 Jul 2023 07:00 AM
RNS
Investor Presentation
03 Jul 2023 07:00 AM
RNS
Successful clinical validation of Clarava™
29 Jun 2023 04:57 PM
RNS
Result of AGM
06 Jun 2023 07:00 AM
RNS
Notice of AGM and posting of Annual Report
05 Jun 2023 07:01 AM
RNS
2022 Annual Results
05 Jun 2023 07:00 AM
RNS
Proposed US pricing for Tutivia™
31 May 2023 07:00 AM
RNS
Notice of Results
24 May 2023 07:01 AM
RNS
Update re. EKF distribution of shares in Verici Dx
24 Apr 2023 07:00 AM
RNS
Final results timing
24 Apr 2023 07:00 AM
RNS
Final results timing
28 Mar 2023 11:05 AM
RNS
Second Price Monitoring Extn
28 Mar 2023 11:00 AM
RNS
Price Monitoring Extension
28 Mar 2023 09:05 AM
RNS
Second Price Monitoring Extn
28 Mar 2023 09:00 AM
RNS
Price Monitoring Extension
27 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
27 Mar 2023 11:05 AM
RNS
Second Price Monitoring Extn
27 Mar 2023 11:00 AM
RNS
Price Monitoring Extension
22 Mar 2023 07:00 AM
RNS
Operational Update
21 Mar 2023 04:40 PM
RNS
Second Price Monitoring Extn
21 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
13 Mar 2023 07:00 AM
RNS
Statement re. Silicon Valley Bank
09 Mar 2023 07:00 AM
RNS
Two key patents granted in the US
02 Mar 2023 07:00 AM
RNS
CLIA Certificate of Compliance
27 Feb 2023 02:00 PM
RNS
Price Monitoring Extension
07 Dec 2022 07:00 AM
RNS
Director/PDMR Shareholding
01 Dec 2022 06:07 PM
RNS
Correction: Holding(s) in Company
03 Oct 2022 07:00 AM
RNS
Product rebranding as TutiviaT
07 Sep 2022 07:00 AM
RNS
Half-year Report
06 Sep 2022 07:00 AM
RNS
Positive results for Clarava from validation study
05 Sep 2022 07:00 AM
RNS
Notice of Results
02 Sep 2022 04:41 PM
RNS
Second Price Monitoring Extn
02 Sep 2022 04:35 PM
RNS
Price Monitoring Extension
27 Jun 2022 03:17 PM
RNS
Result of AGM and voting results
24 Jun 2022 07:00 AM
RNS
Holding(s) in Company
20 Jun 2022 07:30 AM
RNS
Distribution of Verici Dx shares by EKF
16 Jun 2022 07:00 AM
RNS
Investor Presentation
15 Jun 2022 10:57 AM
RNS
CEO Video Interview
14 Jun 2022 09:00 AM
RNS
Further data from TutevaT validation study
09 Jun 2022 07:00 AM
RNS
Commercial Team Appointments
25 May 2022 12:00 PM
RNS
Posting of Annual Report & Accounts
19 May 2022 07:00 AM
RNS
Final Results
12 May 2022 07:00 AM
RNS
Results of TutevaT clinical validation study
01 Apr 2022 07:00 AM
RNS
Clinical Validation Study Update

Verici Dx is an immuno-diagnostics company that produces advanced clinical tests and organ transplant platforms for kidney transplant patients.

Verici Dx share price is listed in London under the ticker VRCI.

UK 100

Latest directors dealings